Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Chemotherapy|April 15, 2015
Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two CentersInci Alacacioglu, Serife S Medeni, Guner H Ozsan, et al.Asian Pacific Journal of Cancer Prevention : APJCP|January 22, 2015
Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-Izmir oncology group studyAhmet Alacacioglu, Eda Ulger, Umut Varol, et al.Medical Oncology (Northwood, London, England)|June 11, 2014
Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivorsAhmet Alacacioglu, Eda Ulger, Umut Varol, et al.Future Oncology (London, England)|June 9, 2023
Unmet clinical needs and challenges in the management of acute leukemia in Turkey: a modified Delphi studyMutlu Arat, Inci Alacacioglu, Ali Zahit Bolaman, et al.Clinical Lymphoma, Myeloma & Leukemia|June 1, 2021
A Real-life Turkish Experience of Venetoclax Treatment in High-risk Myelodysplastic Syndrome and Acute Myeloid LeukemiaAliihsan Gemici, Fahir Ozkalemkas, Mehmet Hilmi Dogu, et al.Clinical Lymphoma, Myeloma & Leukemia|June 3, 2020
Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory MyelomaMeral Beksac, Yildiz Aydin, Hakan Goker, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 6, 2018
A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 studyEmre Tekgündüz, Mehmet Yılmaz, Mehmet Ali Erkurt, et al.Hematological Oncology|May 22, 2023
Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world dataElif Birtas Atesoglu, Zafer Gulbas, Ant Uzay, et al.BMC Cancer|October 11, 2025
Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry projectIbrahim Ethem Pinar, Serhat Celik, Merve Gokcen Polat, et al.Journal of Clinical Medicine|October 29, 2025
Clinical Characteristics, Treatment Approaches, and Survival Predictors in Adult Acute Myeloid Leukemia: Interim Results from the Turkish Society of Hematology AML RegistryVolkan Karakus, Ibrahim Ethem Pinar, Utku Iltar, et al.Pageof 3